Zomedica Pharmaceuticals Corp.
(TSX Venture Exchange : ZOM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.95%42.960.9%$1172.19m
LLYEli Lilly and Company
1.04%124.001.0%$1160.63m
JNJJohnson & Johnson
0.86%136.590.6%$960.96m
MRKMerck & Co., Inc.
1.12%80.720.6%$933.10m
BMYBristol-Myers Squibb Company
1.70%50.981.4%$779.97m
ABBVAbbVie, Inc.
1.60%80.012.2%$667.49m
AZNAstraZeneca PLC Sponsored ADR
1.27%40.951.3%$191.16m
NVSNovartis AG Sponsored ADR
0.30%90.780.2%$183.03m
GSKGlaxoSmithKline plc Sponsored ADR
0.03%40.550.2%$135.60m
NVONovo Nordisk A/S Sponsored ADR Class B
0.28%49.800.1%$67.28m
SNYSanofi Sponsored ADR
-0.36%41.180.2%$36.78m
LCILannett Company, Inc.
0.64%9.4136.7%$16.84m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.70%1.801.7%$0.06m
EPIXESSA Pharma Inc
1.96%3.640.1%$0.04m

Company Profile

Zomedica Pharmaceuticals Corp. is a pharmaceutical company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its products include novel diagnostics and therapeutics that emphasize patient and practice health. The company was founded by Gerald L. Solensky, Jr. on May 14, 2015 and is headquartered in Ann Arbor, MI.